Asthma is a common complex disorder and has been subject to intensive omics research for disease susceptibility and therapeutic innovation. Candidate biomarkers of asthma and its precision treatment demand that they stand the test of multiomics data triangulation before they can be prioritized for clinical applications. We classified the biomarkers of asthma after a search of the literature and based on whether or not a given biomarker candidate is reported in multiple omics platforms and methodologies, using PubMed and Web of Science, we identified omics studies of asthma conducted on diverse platforms using keywords, such as asthma, genomics, metabolomics, and epigenomics. We extracted data about asthma candidate biomarkers from 73 articles and developed a catalog of 190 potential asthma biomarkers (167 human, 23 animal data), comprising DNA loci, transcripts, proteins, metabolites, epimutations, and noncoding RNAs. The data were sorted according to 13 omics types: genomics, epigenomics, transcriptomics, proteomics, interactomics, metabolomics, ncRNAomics, glycomics, lipidomics, environmental omics, pharmacogenomics, phenomics, and integrative omics. Importantly, we found that 10 candidate biomarkers were apparent in at least two or more omics levels, thus promising potential for further biomarker research and development and precision medicine applications. This multiomics catalog reported herein for the first time contributes to future decision-making on prioritization of biomarkers and validation efforts for precision medicine in asthma. The findings may also facilitate meta-analyses and integrative omics studies in the future.
Get full access to this article
View all access options for this article.
References
1.
AdamkoDJ, SykesBD, and RoweBH. (2012). The metabolomics of asthma: Novel diagnostic potential. Chest, 141, 1295–1302.
2.
AkenBL, AylingS, BarrellD, et al. (2016). The Ensembl gene annotation system. Database (Oxford), 2016, 1–19.
3.
AustinPJ, TsitsiouE, BoardmanC, et al. (2016). Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. J Allergy Clin Immunol, 139, 780–789.
4.
BalanticM, RijavecM, FlezarM, et al. (2013). A polymorphism in ORMDL3 is associated not only with asthma without rhinitis but also with chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol, 23, 256–261.
5.
BalanticM, RijavecM, Skerbinjek, et al. (2012). Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms. Mol Diagn Ther, 16, 173–180.
6.
BaldiniM, LohmanIC, HalonenM, et al. (1999). A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol, 20, 976–983.
7.
BarnesPJ, and AdcockIM. (1998). Transcription factors and asthma. Eur Respir J, 12, 221–234.
8.
BatraJ, RajpootR, AhluwaliaJ, et al. (2007). A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels. J Med Genet, 44, 397–403.
9.
BatraJ, SharmaSK, and GhoshB. (2006). Arylamine N-acetyltransferase gene polymorphisms: Markers for atopic asthma, serum IgE and blood eosinophil counts. Pharmacogenomics, 7, 673–682.
10.
BønnelykkeK, SparksR, WaageJ, and MilnerJD. (2015). Genetics of allergy and allergic sensitization: Common variants, rare mutations. Curr Opin Immunol, 36, 115–126.
BretonCV, ByunHM, WentenM, et al. (2009). Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med, 180, 462–467.
13.
BrookPO, PerryMM, AdcockIM, and DurhamAL. (2015). Epigenome-modifying tools in asthma. Epigenomics, 7, 1017–1032.
14.
BrutscheMH, BrutscheIC, WoodP, et al. (2001). Apoptosis signals in atopy and asthma measured with cDNA arrays. Clin Exp Immunol, 123, 181–187.
15.
BunyavanichS, and SchadtEE. (2015). Systems biology of asthma and allergic diseases: A multiscale approach. J Allergy Clin Immunol, 135, 31–42.
16.
ByrnesR, FahyE, and SubramaniamS. (2007). A Laboratory information management system for high throughput experimental lipidomics: Minimal information required for the analysis of lipidomics experiments (MIALE). J Assoc Lab Automat, 12, 230–238.
17.
CarraroS, GiordanoG, RenieroF, et al. (2013). Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy, 68, 110–117.
18.
ChogtuB, BhattacharjeeD, and MagazineR. (2016). Epigenetics: The New Frontier in the Landscape of Asthma. Scientifica (Cairo) 2016,4638949.
19.
ChoiH, TabashidzeN, RossnerPJr., et al. (2017). Altered vulnerability to asthma at various levels of ambient Benzo[a]Pyrene by CTLA4, STAT4 and CYP2E1 polymorphisms. Environ Pollut, 231, 1134–1144.
20.
ChouCH, ChangNW, ShresthaS, et al. (2016). miRTarBase 2016: Updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res, 44, D239–D247.
21.
ChuangHY, HofreeM, and IdekerT. (2010). A decade of systems biology. Annu Rev Cell Dev Biol, 26, 721–744.
22.
ChungKF, and BarnesPJ. (1999). Cytokines in asthma. Thorax, 54, 825–857.
23.
CooksonW. (2002). Genetics and genomics of asthma and allergic diseases. Immunol Rev, 190, 195–206.
24.
DahlinA, and TantisiraKG. (2012). Integrative systems biology approaches in asthma pharmacogenomics. Pharmacogenomics, 13, 1387–1404.
25.
DolganovGM, WoodruffPG, NovikovAA, et al. (2001). A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects. Genome Res, 11, 1473–1483.
26.
FangQ, ZhaoH, WangA, GongY, and LiuQ. (2011). Association of genetic variants in chromosome 17q21 and adult onset on asthma in Chinese Han population. BMC Med Genet, 12, 1–7.
27.
FerreiraMA, MathesonMC, TangCS, et al. (2014). Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J Allergy Clin Immunol, 133, 1564–1571.
28.
GarbackiN, Di ValentinE, Huynh-ThuVA, et al. (2011). MicroRNAs profiling in murine models of acute and chronic asthma: A relationship with mRNAs targets. PLoS One 6,e16509.
29.
GrayKA, YatesB, SealRL, et al. (2015). Genenames.org: The HGNC resources in 2015. Nucleic Acids Res, 43, D1079–D1085.
30.
HanselNN, and DietteGB. (2007). Gene expression profiling in human asthma. Proc Am Thorac Soc,, 4, 32–36.
31.
HastieAT, SteeleC, DunawayCW, et al. (2018). Complex association patterns for inflammatory mediators in induced sputum from subjects with asthma. Clin Exp Allergy. In. press.
32.
HawkinsGA, LazarusR, SmithRS, et al. (2009). The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol, 123, 1376–1383.
33.
HersbergerM, ThunGA, ImbodenM, et al. (2010). Association of STR polymorphisms in CMA1 and IL-4 with asthma and atopy: The SAPALDIA cohort. Hum Immunol, 71, 1154–1160.
34.
HershCP, RabyBA, Soto-QuirosME, et al. (2007). Comprehensive testing of positionally cloned asthma genes in two populations. Am J Respir Crit Care Med, 176, 849–857.
35.
HirotaT, TakahashiA, KuboM, et al. (2011). Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet, 43, 893–896.
36.
HongSJ, KimHB, KangMJ, et al. (2007). TNF-alpha (−308 G/A) and CD14 (-159T/C) polymorphisms in the bronchial responsiveness of Korean children with asthma. J Allergy Clin Immunol, 119, 398–404.
37.
HouX, WanH, AiX, et al. (2016). Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma. Clin Respir J, 10, 371–379.
38.
HrovatinK, and KunejT. (2018a) Classification of heterogeneous genetic variations of microRNA regulome in cancer. Cancer Lett, 419, 128–138.
39.
HrovatinK, and KunejT. (2018b) Classification of miRNA-related sequence variations. Epigenomics, 10, 463–481.
40.
HuoX, ZhangK, YiL, et al. (2016). Decreased epithelial and plasma miR-181b–5p expression associates with airway eosinophilic inflammation in asthma. Clin Exp Allergy, 46, 1281–1290.
41.
HwangS, SonSW, KimSC, et al. (2008). A protein interaction network associated with asthma. J Theor Biol, 252, 722–731.
JinY, HuD, PetersonEL, et al. (2010). Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients. J Allergy Clin Immunol, 126, 618–625.
44.
JungJ, KimSH, LeeHS, et al. (2013). Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Clin Exp Allergy, 43, 425–433.
45.
KamadaF, MashimoY, InoueH, et al. (2007). The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene. Int Arch Allergy Immunol, 144, 275–286.
46.
KangYP, LeeWJ, HongJY, et al. (2014). Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: Lipid levels in asthmatics and corticosteroid-treated asthmatic patients. J Proteome Res, 13, 3919–3929.
47.
KavalarMS, BalanticM, SilarM, et al. (2012). Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma. Int J Immunogenet, 39, 20–25.
48.
KellyRS, DahlinA, McGeachieMJ, et al. (2017). Asthma metabolomics and the potential for integrative omics in research and the clinic. Chest, 151, 262–277.
49.
KeskinO, UlucaU, BirbenE, et al. (2016). Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation. Pediatr Allergy Immunol, 27, 507–513.
50.
KimEG, ShinHJ, LeeCG, et al. (2010). DNA methylation and not allelic variation regulates STAT6 expression in human T cells. Clin Exp Med, 10, 143–152.
51.
KimSH, KimYK, ParkHW, et al. (2007). Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics, 17, 295–304.
52.
KimSH, YeYM, LeeHY, et al. (2011). Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy. J Clin Pharm Ther, 36, 399–405.
53.
KristanSS, MalovrhMM, SilarM, et al. (2009). Airway angiogenesis in patients with rhinitis and controlled asthma. Clin Exp Allergy, 39, 354–360.
54.
KwonNH, KimJS, LeeJY, et al. (2008). DNA methylation and the expression of IL-4 and IFN-gamma promoter genes in patients with bronchial asthma. J Clin Immunol, 28, 139–146.
55.
LapriseC, SladekR, PontonA, et al. (2004). Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics 5,21.
56.
LauMY, DharmageSC, BurgessJA, et al. (2017). The interaction between farming/rural environment and TLR2, TLR4, TLR6 and CD14 genetic polymorphisms in relation to early- and late-onset asthma. Sci Rep 7,43681.
57.
LeungTF, ChanIH, WongGW, et al. (2007). Association between candidate genes and lung function growth in Chinese asthmatic children. Clin Exp Allergy, 37, 1480–1486.
58.
LiuF, QinHB, XuB, et al. (2012). Profiling of miRNAs in pediatric asthma: Upregulation of miRNA-221 and miRNA-485-3p. Mol Med Rep, 6, 1178–1182.
59.
LopertA, RijavecM, ZavbiM, et al. (2013). Asthma treatment outcome in adults is associated with rs9910408 in TBX21 gene. Sci Rep 3,2915.
60.
Lovinsky-DesirS, and MillerRL. (2012). Epigenetics, asthma, and allergic diseases: A review of the latest advancements. Curr Allergy Asthma Rep, 12, 211–220.
61.
MakJC, KoFW, ChuCM, et al. (2007). Polymorphisms in the IL-4, IL-4 receptor alpha chain, TNF-alpha, and lymphotoxin-alpha genes and risk of asthma in Hong Kong Chinese adults. Int Arch Allergy Immunol, 144, 114–122.
62.
MakJC, LeungHC, HoSP, et al. (2006). Analysis of TGF-beta(1) gene polymorphisms in Hong Kong Chinese patients with asthma. J Allergy Clin Immunol, 117, 92–96.
63.
MarcMM, KorosecP, KosnikM, et al. (2004). Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma. Am J Respir Cell Mol Biol, 31, 216–219.
64.
MartinezB, BarriosK, VergaraC, et al. (2007). A NOS1 gene polymorphism associated with asthma and specific immunoglobulin E response to mite allergens in a Colombian population. Int Arch Allergy Immunol, 144, 105–113.
65.
MasiniE, GianniniL, NistriS, et al. (2008). Ceramide: A key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation. J Pharmacol Exp Ther, 324, 548–557.
66.
MatsudaA, HirotaT, AkahoshiM, et al. (2005). Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet, 14, 2779–2786.
67.
MiyakeY, TanakaK, and ArakawaM. (2013). Relationship between polymorphisms in IL4 and asthma in Japanese women: The Kyushu Okinawa Maternal and Child Health Study. J Investig Allergol Clin Immunol, 23, 242–247.
68.
MoffattMF, GutIG, DemenaisF, et al. (2010). A large-scale, consortium-based genomewide association study of asthma. N Engl J Med, 363, 1211–1221.
69.
MorganT, BajrovicN, SilarM, et al. (2009) Aspirin-induced COX-2 overexpression in monocytes of aspirin-intolerant patients. Int Arch Allergy Immunol, 149, 378–384.
70.
MottaA, ParisD, D'AmatoM, et al. (2014). NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J Proteome Res, 13, 6107–6120.
71.
NadeauK, McDonald-HymanC, NothEM, et al. (2010). Ambient air pollution impairs regulatory T-cell function in asthma. J Allergy Clin Immunol, 126, 845–852.
72.
Nicodemus-JohnsonJ, NaughtonKA, SudiJ, et al. (2016). Genome-Wide Methylation Study Identifies an IL-13-induced Epigenetic Signature in Asthmatic Airways. Am J Respir Crit Care Med, 193, 376–385.
73.
NorthSJ, GuntenS, AntonopoulosA, et al. (2012). Glycomic analysis of human mast cells, eosinophils and basophils. Glycobiology, 22, 12–22.
74.
Padron-MoralesJ, SanzC, DavilaI, et al. (2013). Polymorphisms of the IL12B, IL1B, and TNFA genes and susceptibility to asthma. J Investig Allergol Clin Immunol, 23, 487–494.
75.
PalmerCN, IsmailT, LeeSP, et al. (2007). Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol, 120, 64–68.
ParkBL, ParkSM, ParkJS, et al. (2010). Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep, 43, 445–449.
78.
ParkCS, and RhimT. (2011). Application of proteomics in asthma research. Expert Rev Proteomics, 8, 221–230.
79.
PereraF, TangWY, and HerbstmanJ. (2009). Relation of DNA methylation of 5′-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS One 4,e4488.
80.
PirihN, and KunejT. (2017). Toward a taxonomy for multi-omics science? Terminology development for whole genome study approaches by omics technology and hierarchy. OMICS, 21, 1–16.
81.
PirihN, and KunejT. (2018). An updated taxonomy and a graphical summary tool for optimal classification and comprehension of omics research. OMICS, 22, 337–353.
82.
PolonikovAV, IvanovVP, SolodilovaMA, et al. (2007). The relationship between polymorphisms in the glutamate cysteine ligase gene and asthma susceptibility. Respir Med, 101, 2422–2424.
83.
PuaHH, and AnselKM. (2015). MicroRNA regulation of allergic inflammation and asthma. Curr Opin Immunol, 36, 101–108.
84.
PykalainenM, KinosR, ValkonenS, et al. (2005). Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol, 115, 80–87.
85.
RedenšekS, DolžanV, and KunejT. (2018). From genomics to omics landscapes of Parkinson's disease: Revealing the molecular mechanisms. OMICS, 22, 1–16.
86.
RijavecM, KorošecP, ŽavbiM, et al. (2014). Let-7a is differentially expressed in bronchial biopsies of patients with severe asthma. Sci Rep 4,6103.
87.
SalamMT, GaudermanWJ, McConnellR, et al. (2007). Transforming growth factor- 1 C-509T polymorphism, oxidant stress, and early-onset childhood asthma. Am J Respir Crit Care Med, 176, 1192–1199.
88.
SaudeEJ, SkappakCD, RegushS, et al. (2011). Metabolomic profiling of asthma: Diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol, 127, 757–764.
89.
SchedelM, DepnerM, SchoenC, et al. (2006). The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir Res 7,91.
90.
SharmaA, KumarM, AhmadT, et al. (2012). Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. J Appl Physiol (1985), 113, 459–464.
91.
SharmaS, and GhoshB. (2009). Promoter polymorphism in the MS4A2 gene and asthma in the Indian population. Int Arch Allergy Immunol, 149, 208–218.
92.
SimpsonLJ, PatelS, BhaktaNR, et al. (2014). A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production. Nat Immunol, 15, 1162–1170.
93.
TantisiraKG, LimaJ, SylviaJ, et al. (2009). 5-lipoxygenase pharmacogenetics in asthma: Overlap with Cys-leukotriene receptor antagonist loci. Pharmacogenet Genomics, 19, 244–247.
94.
TantisiraKG, SilvermanES, MarianiTJ, et al. (2007). FCER2: A pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol, 120, 1285–1291.
95.
The UniProt Consortium. (2017). UniProt: The universal protein knowledgebase. Nucleic Acids Res, 45, D158–D169.
96.
TormanenS, KorppiM, LauhkonenE, et al. (2017). Toll-like receptor 1 and 10 gene polymorphisms are linked to postbronchiolitis asthma in adolescence. Acta Paediatr, 107, 134–139.
97.
VercelliD. (2008). Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol, 8, 169–182.
98.
VicenteCT, ReverzJA, and FerreiraMAR. (2017). Lessons from ten years of genome-wide association studies of asthma. Clin Transl Immunology 6,e165.
99.
von MutiusE. (2009). Gene-environment interactions in asthma. J Allergy Clin Immunol, 123, 3–11.
100.
VonkJM, PostmaDS, MaarsinghH, et al. (2010). Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response. Pharmacogenet Genomics, 20, 179–186.
101.
WanYI, ShrineNR, SolerAM, et al. (2012). Genome-wide association study to identify genetic determinants of severe asthma. Thorax, 67, 762–768.
102.
WishartDS, TzurD, KnoxC, et al. (2007). HMDB: The Human Metabolome Database. Nucleic Acids Res, 35, D521–D526.
103.
YamadaY, KosakaK, MiyazawaT, et al. (2014). miR-142-3p enhances FcepsilonRI-mediated degranulation in mast cells. Biochem Biophys Res Commun, 443, 980–986.
104.
YickCY, ZwindermanAH, KunstPW, et al. (2013). Transcriptome sequencing (RNA-Seq) of human endobronchial biopsies: Asthma versus controls. Eur Respir J, 42, 662–670.
105.
ŽavbiM, KorošecP, FležarM, et al. (2016). Polymorphisms and haplotypes of the chromosome locus 17q12-17q21.1 contribute to adult asthma susceptibility in Slovenian patients. Hum Immunol, 77, 527–534.
106.
ZhaoJ, ShangH, CaoX, et al. (2017). Association of polymorphisms in TLR2 and TLR4 with asthma risk: An update meta-analysis. Medicine (Baltimore) 96,e7909.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
